TAK 50 EG

Informazioni principali

  • Nome commerciale:
  • TAK 50 EG
  • Forma farmaceutica:
  • EG granulare emulsionato
  • Utilizzare per:
  • Piante
  • Tipo di medicina:
  • Agrochimico

Documenti

  • per i professionisti:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per i professionisti.

Localizzazione

  • Disponibile in:
  • TAK 50 EG
    Svizzera
  • Lingua:
  • italiano

Informazioni terapeutiche

  • Gruppo terapeutico:
  • Insetticida

Altre informazioni

Status

  • Fonte:
  • UFAG - Ufficio federale dell'agricoltura. OFAG - Office fédéral de l'agriculture. BLW - Bundesamt für Landwirtschaft.
  • Numero dell'autorizzazione:
  • W-6953-1
  • Ultimo aggiornamento:
  • 18-11-2018

Foglio illustrativo: composizione, posologia, indicazioni, interazioni, gravidanza, allattamento, effetti indesiderati, controindicazioni

Denominazione commerciale: TAK 50 EG

Elenco dei prodotti fitosanitari (stato: 06.11.2018)

Categoria di prodotti:

Titolare dell'autorizzazione:

Numero federale di omologazione:

Insetticida

Stähler Suisse SA

W-6953-1

Principio:

Tenore:

Codice di formulazione:

Principio attivo: Lambda-Cialotrina 5 %

EG granulare emulsionato

Applicazioni

A

Coltura

Agente

patogeno/Efficacia

Dosaggio

Restrizioni

B Fragola

Antonomo delle

fragole o dei lamponi

Tripidi

Concentrazione: 0.02 %

Dose: 0.2 kg/ha

Termine d'attesa: 3 Settimane

1, 2, 3, 4

B Lampone

Antonomo delle

fragole o dei lamponi

Concentrazione: 0.04 %

Dose: 0.4 kg/ha

Termine d'attesa: 3 Settimane

3, 4, 5, 6

B Lampone

Verme del lampone

Concentrazione: 0.02 %

Dose: 0.2 kg/ha

Termine d'attesa: 3 Settimane

3, 4, 5, 6

O Pero / Nashi

Psille del pero

Concentrazione: 0.03 %

Dose: 0.48 kg/ha

Applicazione: Inverno inoltrato.

3, 4, 7, 8

Portainnesti di vite

(vivai)

Scafoideo

Concentrazione: 0.02 %

1, 3, 4, 9, 10

Aglio

Cipolle

Porro

Scalogni

Afidi

Minatrici

Nottue terricole o

vermi grigi

Tignola del porro

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 2 Settimane

1, 3, 4, 11,

G Alchechengio

Angurie

Cetrioli

Melanzana

Meloni

Peperone

Pepino

Afidi

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Concentrazione: 0.02 %

Dose: 0.2 kg/ha

Termine d'attesa: 3 Giorni

1, 3, 4, 12,

A

Coltura

Agente

patogeno/Efficacia

Dosaggio

Restrizioni

Pomodori

Zucche (buccia non

commestibile)

Zucche con buccia

commestibile

G Asparagi

Afidi

Criocera a dodici punti

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Applicazione: Dopo il raccolto.

1, 3, 4, 14

Barbabietola

Bietola

Spinaci

Afidi

Altiche

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 1 Settimane

1, 3, 4, 12,

Carciofi

Cardo

Mais dolce

Scorzonera

Topinambur

Tuberina

Zucca da olio

Afidi

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 2 Settimane

1, 3, 4, 12,

Carote

Finocchio dolce

Pastinaca

Prezzemolo tuberoso

Sedano

Afidi

Minatrici

Nottue terricole o

vermi grigi

Psilla della carota

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 2 Settimane

1, 3, 4, 12,

Carote

Finocchio dolce

Pastinaca

Prezzemolo tuberoso

Sedano

Mosca della carota

Dose: 0.2 kg/ha

Termine d'attesa: 2 Settimane

1, 3, 4, 15

Cavoli / rape da taglio

Cima di rapa

Insalate asiatiche

(Brassicacee)

Rucola

Afidi

Altiche

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 1 Settimane

1, 3, 4, 12,

G Cicoria belga

Afidi

Minatrici

Dose: 0.2 kg/ha

1, 3, 4, 12,

A

Coltura

Agente

patogeno/Efficacia

Dosaggio

Restrizioni

Nottue terricole o

vermi grigi

Tripidi

G Crescione

Afidi

Altiche

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 1 Settimane

1, 3, 4, 16

G Erbette da cucina

Afidi

Altiche

Minatrici

Nottue terricole o

vermi grigi

Psilla della carota

Tignola del porro

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 1 Settimane

1, 3, 4, 12,

Fagioli

Fave

Piselli

Afidi

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 1 Settimane

1, 3, 4, 12,

G Insalate (Asteracee)

Afidi

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 1 Settimane

1, 3, 4, 12,

G Rabarbaro

Afidi

Altiche

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Applicazione: Dopo il raccolto.

1, 3, 4, 14

G Rabarbaro

Afidi

Altiche

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 2 Settimane

1, 3, 4, 12,

G Rafano rusticana /

Ramolaccio

Ramolaccio

Rapa di Brassica rapa e

B. napus

Afidi

Altiche

Minatrici

Nottue terricole o

vermi grigi

Dose: 0.2 kg/ha

Termine d'attesa: 2 Settimane

1, 3, 4, 12,

A

Coltura

Agente

patogeno/Efficacia

Dosaggio

Restrizioni

Ravanello

Tripidi

G Specie di cavoli

Afidi

Aleurodidi

Altiche

Cavolaie

Cecidomia del cavolo

Minatrici

Nottue (defogliatrici)

Nottue terricole o

vermi grigi

Tignola delle Crocifere

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 2 Settimane

1, 3, 4, 12,

G Valerianella

Afidi

Minatrici

Nottue terricole o

vermi grigi

Tripidi

Dose: 0.2 kg/ha

Termine d'attesa: 3 Settimane

1, 3, 4, 13,

Barbabietola da

foraggio

Barbabietola da

zucchero

Afidi

Altiche della

barbabietola

Mosca della

barbabietola

Nottue terricole o

vermi grigi

Dose: 0.15 kg/ha

Termine d'attesa: 6 Settimane

1, 3, 4, 18

Cereali

Cloropo del grano

Nottue terricole o

vermi grigi

Dose: 0.15 kg/ha

Termine d'attesa: 6 Settimane

1, 3, 4, 19

Cereali autunnali

Afidi vettori di virus

Dose: 0.15 kg/ha

Termine d'attesa: 6 Settimane

Applicazione: In autunno.

1, 3, 4, 19

Colza

Punteruolo delle

silique delle crocifere

Azione parziale:

Cecidomia delle

silique delle crocifere

Dose: 0.15 kg/ha

Termine d'attesa: 6 Settimane

Applicazione: Fino allo stadio fine

sviluppo dei bottoni fiorali. (BBCH

59).

1, 3, 4, 19

Colza

Nottue terricole o

vermi grigi

Dose: 0.15 kg/ha

Termine d'attesa: 6 Settimane

1, 3, 4, 19

Colza

Punteruolo degli steli

della colza

Dose: 0.2 kg/ha

Termine d'attesa: 6 Settimane

Applicazione: Stadi 31-53 (BBCH).

1, 3, 4, 19

Colza autunnale

Altica della colza

Dose: 0.15 kg/ha

1, 3, 4, 19

A

Coltura

Agente

patogeno/Efficacia

Dosaggio

Restrizioni

Tentredine delle

crocifere

Termine d'attesa: 6 Settimane

Applicazione: In autunno.

Luppolo

Afidi

Concentrazione: 0.015 %

Termine d'attesa: 3 Settimane

Applicazione: Dallo stadio BBCH 37.

3, 4, 5

Mais

Mosca frit

Nottue terricole o

vermi grigi

Dose: 0.15 kg/ha

Termine d'attesa: 6 Settimane

1, 3, 4, 18

Patate

Dorifora della patata

Dose: 0.15 kg/ha

Termine d'attesa: 3 Settimane

1, 3, 4, 20

Patate

Nottue terricole o

vermi grigi

Dose: 0.15 kg/ha

Termine d'attesa: 3 Settimane

1, 3, 4, 18

Patate per la

produzione di tuberi-

seme

Afidi vettori di virus

Dose: 0.15 kg/ha

1, 4, 21

Pisello proteico

Tortrice del pisello

Dose: 0.15 kg/ha

1, 3, 4, 18

Colture da fiore e

piante verdi

Afidi

Aleurodidi

Cecidomie

Crisomelidi

Miridi

Nottue terricole o

vermi grigi

Sciaridi

Tripidi

Concentrazione: 0.02 %

Dose: 0.2 kg/ha

1, 3, 4

Rose

Larve defogliatrici

Concentrazione: 0.02 %

Dose: 0.2 kg/ha

1, 3, 4

Restrizioni e osservazioni:

SPe 3: per proteggere organismi acquatici dagli effetti della deriva rispettare una zona tampone

non trattata di 20 m dalle acque superficiali. Tale distanza può essere ridotta attuando misure di

riduzione della deriva secondo le istruzioni dell'UFAG.

La dose indicata si riferisce allo stadio "piena fioritura fino all'inizio dell'arrossamento dei

frutticini", 4 piante/m², trattamento con una quantità standard di poltiglia di 1000 l/ha.

SPe 8: Pericoloso per le api - Può entrare in contatto con piante in fiore o che presentano melata

soltanto di sera, al di fuori del periodo di volo delle api. Applicazione soltanto in serre chiuse, a

condizione che non siano presenti impollinatori.

Durante la preparazione della poltiglia: Indossare occhiali di protezione o una visiera.

SPe 3: per proteggere organismi acquatici dagli effetti della deriva rispettare una zona tampone

non trattata di 50 m dalle acque superficiali. Tale distanza può essere ridotta attuando misure di

riduzione della deriva secondo le istruzioni dell'UFAG.

Per i lamponi estivi la dose indicata si riferisce allo stadio "inizio fioritura fino a 50% dei fiori

aperti", trattamento con una quantità standard di poltiglia di 1000 l/ha. Per i lamponi autunnali la

dose si riferisce ad una siepe di 150 - 170 cm d'altezza, trattamento con una quantità standard di

poltiglia di 1000 l/ha.

La dose indicata si riferisce a un volume di alberi di 10'000 m³/ha.

SPe 3: per proteggere organismi acquatici dagli effetti della deriva rispettare una zona tampone

non trattata di 100 m dalle acque superficiali. Tale distanza può essere ridotta attuando misure di

riduzione della deriva secondo le istruzioni dell'UFAG.

Trattamento soltanto su indicazione dei servizi fitosanitari cantonali.

10.2 - 3 trattamenti a intervalli di 14 giorni.

11.Al massimo 3 trattamenti per coltura con questo prodotto o qualsiasi altro prodotto contenente tale

sostanza attiva.

12.Trattamenti a intervalli di 7-14 giorni.

13.Al massimo 2 trattamenti per coltura con questo prodotto o qualsiasi altro prodotto contenente tale

sostanza attiva.

14.Al massimo 2 trattamenti per anno e particella con questo prodotto o qualsiasi altro prodotto

contenente tale sostanza attiva

15.Trattamenti solo durante il volo (secondo numero critico delle catture) a intervalli di almeno 7

giorni.

16.Al massimo 1 trattamento per coltura con questo prodotto o qualsiasi altro prodotto contenente

tale sostanza attiva

17.Trattamenti a intervalli di almeno 7 giorni.

18.Al massimo un 1 trattamento per coltura.

19.Al massimo 1 trattamento per coltura e anno.

20.SPa 1: Per evitare l'insorgere di resistenza non applicare questo o altri prodotti contenenti un

piretroide per più di 1 volta per coltura.

21.Solamente per colture in tunnel o in serra

Caratterizzazione di pericolo:

Tenere fuori dalla portata dei bambini.

EUH 401 Per evitare rischi per la salute umana e per l'ambiente, seguire le istruzioni per l'uso.

H302 Nocivo se ingerito.

H319 Provoca grave irritazione oculare.

H410 Molto tossico per gli organismi acquatici con effetti di lunga durata.

SP 1 Non contaminare l'acqua con il prodotto o il suo imballaggio.

SPe 8 Pericoloso per le api

Avvertenza:

Attenzione

Simboli e indicazioni di pericolo:

Identificatore chiave

GHS07

GHS09

Simbolo

Indicazione di pericolo Attenzione pericolo Pericoloso per l'ambiente acquatico

In caso di dubbio valgono soltanto i documenti originali dell'omologazione. La menzione di un prodotto,

principio attivo o di una ditta non rappresenta alcuna raccomandazione.

17-1-2019

Outcome of the public consultation on the draft statement on genotoxicity assessment of chemical mixtures

Outcome of the public consultation on the draft statement on genotoxicity assessment of chemical mixtures

Published on: Wed, 16 Jan 2019 The European Food Safety Authority (EFSA) carried out a public consultation to receive input from the scientific community and all interested parties on the genotoxicity assessment of chemical mixtures. The draft statement was prepared by a dedicated working group of the Scientific Committee and endorsed by the Scientific Committee for public consultation at its 89th plenary meeting of 28‐29 May 2018. The public consultation for this document was open from 26 June until 9 ...

Europe - EFSA - European Food Safety Authority EFSA Journal

17-1-2019

Outcome of the Public Consultation on the draft Guidance on Communication of Uncertainty in Scientific Assessments

Outcome of the Public Consultation on the draft Guidance on Communication of Uncertainty in Scientific Assessments

Published on: Wed, 16 Jan 2019 The first strategic objective of EFSA's strategy 2020 ‘Trusted science for safe food’ is the prioritisation of public and stakeholder engagement in the development of scientific assessment. To achieve this, objective public consultations are a key step for such a strategic framework. The draft Guidance document on communication of uncertainty underwent a web‐based public consultation from 4 May to 24 June 2018. The document provides guidance for communicators on how to com...

Europe - EFSA - European Food Safety Authority EFSA Journal

15-1-2019

EFSA's activities on emerging risks in 2017

EFSA's activities on emerging risks in 2017

Published on: Mon, 14 Jan 2019 The main objectives of EFSA's activities on emerging risks are: (i) to carry out activities to identify emerging risks in the areas within the remit of EFSA; and (ii) to develop and improve emerging risk identification methodologies and approaches. The current technical report summarises the activities of all groups involved in the emerging risk identification procedure, the issues identified in the course of 2017, a description of methodologies being developed and collabo...

Europe - EFSA - European Food Safety Authority EFSA Journal

14-1-2019

Germany Black Ant 2000mg tablets (Zhansheng Weige Chaoyue Xilishi)

Germany Black Ant 2000mg tablets (Zhansheng Weige Chaoyue Xilishi)

These tablets pose a serious risk to your health and should not be taken

Therapeutic Goods Administration - Australia

10-1-2019


Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, London, UK, from 26/11/2018 to 26/11/2018

Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, London, UK, from 26/11/2018 to 26/11/2018

Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, London, UK, from 26/11/2018 to 26/11/2018

Europe - EMA - European Medicines Agency

8-1-2019

Resapath

Resapath

The development of antimicrobial resistance in animal and human bacteria is a major public health issue requiring an integrated approach across all types of medicine, according to the "One Health" concept covering both humans and animals. ANSES has mobilised significant resources to combat antimicrobial resistance, in particular by coordinating the French Surveillance Network for Antimicrobial Resistance in Pathogenic Bacteria of Animal Origin (Resapath), which is devoted to monitoring resistance in bact...

France - Agence Nationale du Médicament Vétérinaire

4-1-2019

Modification of the existing maximum residue levels for lambda‐cyhalothrin in celeries, fennel and rice

Modification of the existing maximum residue levels for lambda‐cyhalothrin in celeries, fennel and rice

Published on: Thu, 03 Jan 2019 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Syngenta Crop Protection AG submitted a request to the competent national authority in Greece to modify the existing maximum residue levels (MRLs) for lambda‐cyhalothrin in celeries, fennel and rice. The data submitted in support of the request were found to be sufficient to derive tentative MRL proposals for the concerned crops. They are tentative as formally the general data gap identified in the ...

Europe - EFSA - European Food Safety Authority EFSA Journal

3-1-2019

Loblaw Companies Limited recalls Life at Home 50 Count Indoor LED Microdot Icicle Lights

Loblaw Companies Limited recalls Life at Home 50 Count Indoor LED Microdot Icicle Lights

Due to a potential manufacturing defect the lights may overheat, posing a burn and fire hazard.

Health Canada

21-12-2018

Funky Chunky, Llc Issues Allergy Alert on Undeclared Almond and Cashew Tree-Nut in 10 Oz. Nutty Choco Pop Found in Chocolate Popcorn Gift Box, Holiday Crowd Pleaser and Crowd Pleaser Gifts

Funky Chunky, Llc Issues Allergy Alert on Undeclared Almond and Cashew Tree-Nut in 10 Oz. Nutty Choco Pop Found in Chocolate Popcorn Gift Box, Holiday Crowd Pleaser and Crowd Pleaser Gifts

Funky Chunky, LLC of Eden Prairie, MN is recalling 10 oz Nutty Choco Pop Gift Box, 50 oz. Holiday Crowd Pleaser and 50 oz. Crowd Pleaser, because it may contain undeclared Almond and Cashew Tree Nut. People who have an allergy or severe sensitivity to Almonds and Cashews run the risk of serious or life-threatening allergic reaction if they consume these products.

FDA - U.S. Food and Drug Administration

20-12-2018

Button batteries: prevent their ingestion by young children and adopt the right reflexes in the event of an accident

Button batteries: prevent their ingestion by young children and adopt the right reflexes in the event of an accident

In view of the numerous cases of very young children(usually under the age of 6) ingesting button batteries, with serious and sometimes fatal consequences, the health authorities are once again alerting parents, carers and health professionals to this little-known health risk and making them aware of the immediate steps to take in the event of an accident.

France - Agence Nationale du Médicament Vétérinaire

20-12-2018

Workshop on Avian Influenza

Workshop on Avian Influenza

Published on: Wed, 19 Dec 2018 Since September 2017, EFSA has been providing ongoing scientific and technical support to the European Commission and Member States (MSs) in the collection, collation, and analysis of epidemiological data relevant to the monitoring of avian influenza (AI) viruses in Europe and third countries. From 2019 onwards, EFSA will also be responsible for collecting, collating, and analysing the data gathered by MSs via their surveillance programmes in poultry and wild birds. To eff...

Europe - EFSA - European Food Safety Authority EFSA Journal

19-12-2018

Beefit capsules

Beefit capsules

Beefit capsules pose a serious risk to your health and should not be taken.

Therapeutic Goods Administration - Australia

18-12-2018

FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects

FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects

[07-26-2016] The U.S. Food and Drug Administration (FDA) approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection).

FDA - U.S. Food and Drug Administration

18-12-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on new steps to promote innovations in medical devices that help advance patient safety

Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on new steps to promote innovations in medical devices that help advance patient safety

FDA announces steps being taken on two medical device programs: finalizing guidance on the Breakthrough Device Program and announcing plans for a new Safer Technologies Program (STeP).

FDA - U.S. Food and Drug Administration

17-12-2018

 Occupational health: aiming to take better account of multiple exposure

Occupational health: aiming to take better account of multiple exposure

Workers can potentially be exposed to numerous health risk factors through their occupations. The question of multiple exposure is a major challenge for all those active in the field of occupational health, safety and prevention. As part of the 2016-2020 National Occupational Health Plan, a review of the measures taken by the main players to address the question of multiple exposure in France and abroad is being published today. This work has helped determine the state of knowledge and the issues surroun...

France - Agence Nationale du Médicament Vétérinaire

17-12-2018

Occupational health: aiming to take better account of multiple exposure

Occupational health: aiming to take better account of multiple exposure

France - Agence Nationale du Médicament Vétérinaire

14-12-2018


European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, from 03/12/2018 to 03/12/2018

European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, from 03/12/2018 to 03/12/2018

European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, from 03/12/2018 to 03/12/2018

Europe - EMA - European Medicines Agency

14-12-2018

Peer review of the pesticide risk assessment for the active substance bromoxynil in light of negligible exposure data submitted

Peer review of the pesticide risk assessment for the active substance bromoxynil in light of negligible exposure data submitted

Published on: Thu, 13 Dec 2018 The conclusions of EFSA following the peer review of the initial risk assessment carried out by the competent authority of the rapporteur Member State France for the pesticide active substance bromoxynil are reported. The European Commission requested EFSA to conduct a peer review and provide its conclusions on whether exposure of humans to bromoxynil can be considered negligible, taking into account the European Commission's draft guidance on this topic. The conclusions w...

Europe - EFSA - European Food Safety Authority Publications

11-12-2018

FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

FDA update on the ongoing investigation into angiotensin II receptor blocker impurities, recalls and current findings.

FDA - U.S. Food and Drug Administration

11-12-2018

THAN YOU tablets

THAN YOU tablets

THAN YOU tablets pose a serious risk to your health and should not be taken.

Therapeutic Goods Administration - Australia

6-12-2018

Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level. The recalled lots of the product have been found to potentially have higher concentrations of ibuprofen.

FDA - U.S. Food and Drug Administration

6-12-2018

FDA Working with Stakeholders to Maintain Effectiveness of Livestock and Horse Dewormers

FDA Working with Stakeholders to Maintain Effectiveness of Livestock and Horse Dewormers

The U.S. Food and Drug Administration announced today that it has requested that animal drug companies voluntarily revise the labels of animal drugs intended to treat certain internal parasites in livestock and horses to add information about antiparasitic resistance.

FDA - U.S. Food and Drug Administration

6-12-2018

Bee health: ANSES reviews the latest scientific developments

Bee health: ANSES reviews the latest scientific developments

ANSES is holding its annual scientific conference on bee health. This event is an opportunity for the Agency to review the latest major developments in research and surveillance in this field. For this seventh edition, ANSES is inviting the various stakeholders involved in the issue to discuss the latest scientific advances, technological innovations and international and local initiatives contributing to adequate prevention and protection of the health of pollinating insects.

France - Agence Nationale du Médicament Vétérinaire

4-12-2018

FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care

FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care

FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care

FDA - U.S. Food and Drug Administration

3-12-2018


Agenda - Regulatory science to 2025: launch of veterinary stakeholder consultation

Agenda - Regulatory science to 2025: launch of veterinary stakeholder consultation

Agenda - Regulatory science to 2025: launch of veterinary stakeholder consultation

Europe - EMA - European Medicines Agency

29-11-2018


Multi-stakeholder workshop to launch consultation on European Medicines Agency (EMA) veterinary regulatory science to 2025, European Medicines Agency, London, UK, from 06/12/2018 to 06/12/2018

Multi-stakeholder workshop to launch consultation on European Medicines Agency (EMA) veterinary regulatory science to 2025, European Medicines Agency, London, UK, from 06/12/2018 to 06/12/2018

Multi-stakeholder workshop to launch consultation on European Medicines Agency (EMA) veterinary regulatory science to 2025, European Medicines Agency, London, UK, from 06/12/2018 to 06/12/2018

Europe - EMA - European Medicines Agency

29-11-2018

ANSES Newsletter in English - N°50 - November 2018

ANSES Newsletter in English - N°50 - November 2018

France - Agence Nationale du Médicament Vétérinaire

26-11-2018


Agenda - Multi-stakeholder workshop with the Heads of Medicines Agencies / European Medicine Agency Task Force on availability of authorised medicines

Agenda - Multi-stakeholder workshop with the Heads of Medicines Agencies / European Medicine Agency Task Force on availability of authorised medicines

Agenda - Multi-stakeholder workshop with the Heads of Medicines Agencies / European Medicine Agency Task Force on availability of authorised medicines

Europe - EMA - European Medicines Agency

24-11-2018

The EFSA‐funded collection of dietary and related data in the general population aged 10‐74 years in Greece

The EFSA‐funded collection of dietary and related data in the general population aged 10‐74 years in Greece

Published on: Fri, 23 Nov 2018 The Hellenic Health Foundation received support from the European Food Safety Authority in order to organise a national nutrition survey according to the methodology described in the EFSA Guidance document and to collect food consumption and related information among 780 adolescents, adults and elderly residing permanently in Greece. The EFSA‐funded data collection was largely based on the protocol of a large scale Greek national nutrition and health survey, called HYDRIA....

Europe - EFSA - European Food Safety Authority Publications

24-11-2018

Lumpy skin disease: Workshop on risk assessment and data collection for epidemiology, control and surveillance

Lumpy skin disease: Workshop on risk assessment and data collection for epidemiology, control and surveillance

Published on: Fri, 23 Nov 2018 Abstract The epidemics of lumpy skin disease in EU has been controlled mainly thanks to the coordinated control measures taken in the Balkan region, based above all on regional vaccination campaign. Since before the epidemics EFSA has been performing risk assessment on LSD to support the decision making process both for EC and also for the national authorities. Periodical meetings with representatives from affected and at risk countries have been organised by EFSA in order...

Europe - EFSA - European Food Safety Authority Publications

24-11-2018

Hazard identification and ranking for poultry at slaughter

Hazard identification and ranking for poultry at slaughter

Published on: Fri, 23 Nov 2018 The Hellenic Health Foundation received support from the European Food Safety Authority in order to organise a national nutrition survey according to the methodology described in the EFSA Guidance document and to collect food consumption and related information among 780 adolescents, adults and elderly residing permanently in Greece. The EFSA‐funded data collection was largely based on the protocol of a large scale Greek national nutrition and health survey, called HYDRIA....

Europe - EFSA - European Food Safety Authority Publications

23-11-2018

FDA Classifies Field Action Related to Fc 500™ And Epics® As Class 1 Recall Beckman Coulter Life Sciences Committed to Helping Customers Take Prompt, Appropriate Actions

FDA Classifies Field Action Related to Fc 500™ And Epics® As Class 1 Recall Beckman Coulter Life Sciences Committed to Helping Customers Take Prompt, Appropriate Actions

Beckman Coulter Life Sciences today announced the previously communicated global voluntary recall launched in January 2018 related to the FC 500™ Series Flow Cytometers (FC 500), COULTER® EPICS® XL™ and COULTER® EPICS® XL-MCL™ Flow Cytometer with System II Software (together referred to as the EPICS) has been classified as Class 1 by the U.S. Food and Drug Administration (FDA).

FDA - U.S. Food and Drug Administration

22-11-2018


Fourth industry stakeholder platform on research and development support, European Medicines Agency, London, UK, from 23/11/2018 to 23/11/2018

Fourth industry stakeholder platform on research and development support, European Medicines Agency, London, UK, from 23/11/2018 to 23/11/2018

Fourth industry stakeholder platform on research and development support, European Medicines Agency, London, UK, from 23/11/2018 to 23/11/2018

Europe - EMA - European Medicines Agency

22-11-2018

Safety and efficacy of Monteban® G100 (narasin) for ducks for fattening

Safety and efficacy of Monteban® G100 (narasin) for ducks for fattening

Published on: Wed, 21 Nov 2018 Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of Monteban® G100 for ducks. Monteban® G100, containing narasin, is intended for the prevention of coccidiosis in ducks for fattening at a dose range of 60–70 mg/kg of complete feed. Narasin from Monteban® G100 is safe for ducks for fattening at a level of 70 mg/kg complete feed...

Europe - EFSA - European Food Safety Authority Publications

21-11-2018

Safety and efficacy of Monteban® G100 (narasin) for chickens for fattening

Safety and efficacy of Monteban® G100 (narasin) for chickens for fattening

Published on: Tue, 20 Nov 2018 The feed additive Monteban® G100, containing the active substance narasin, an ionophore anticoccidial, is intended to control coccidiosis in chickens for fattening at a dose of 60–70 mg/kg complete feed. Narasin is produced by fermentation. Limited data on the taxonomic identification of the production strain did not allow the proper identification of strain NRRL 8092 as Streptomyces aureofaciens. The FEEDAP Panel cannot conclude on the absence of genetic determinants for ...

Europe - EFSA - European Food Safety Authority Publications

21-11-2018

Risk for animal and human health related to the presence of dioxins and dioxin-like PCBs in feed and food

Risk for animal and human health related to the presence of dioxins and dioxin-like PCBs in feed and food

Published on: Tue, 20 Nov 2018 The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of dioxins (PCDD/Fs) and DL‐PCBs in feed and food. The data from experimental animal and epidemiological studies were reviewed and it was decided to base the human risk assessment on effects observed in humans and to use animal data as supportive evidence. The critical effect was on semen quality, following pre‐ and postnatal exposure. The critical s...

Europe - EFSA - European Food Safety Authority Publications

20-11-2018

Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on FDA’s updates to Medical Device Safety Action Plan to enhance post-market safety

Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on FDA’s updates to Medical Device Safety Action Plan to enhance post-market safety

FDA provides updates on medical device safety action plan describing recent actions we’ve taken to enhance device safety including implementation of NEST and registries on women’s health.

FDA - U.S. Food and Drug Administration

20-11-2018

Gilenya (fingolimod): Drug Safety Communication - Severe Worsening of Multiple Sclerosis After Stopping the Medicine

Gilenya (fingolimod): Drug Safety Communication - Severe Worsening of Multiple Sclerosis After Stopping the Medicine

FDA is warning that when the multiple sclerosis (MS) medicine Gilenya (fingolimod) is stopped, the disease can become much worse than before the medicine was started or while it was being taken. This MS worsening is rare but can result in permanent disability.

FDA - U.S. Food and Drug Administration

20-11-2018

Modification of the existing maximum residue levels and setting of import tolerances for pyraclostrobin in various crops

Modification of the existing maximum residue levels and setting of import tolerances for pyraclostrobin in various crops

Published on: Mon, 19 Nov 2018 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant BASF SE submitted two requests to the competent national authority in Germany. The first one, to modify the existing maximum residue levels (MRL) for the active substance pyraclostrobin in various crops and to set import tolerances for sugar canes and American persimmons; the second one to set import tolerances for pineapples and passion fruits/maracujas. The data submitted in support of the request...

Europe - EFSA - European Food Safety Authority Publications

19-11-2018

Certain Option and Personelle sunscreens voluntarily recalled because of bacterial contamination

Certain Option and Personelle sunscreens voluntarily recalled because of bacterial contamination

One lot each of Option Family Sunscreen Lotion SPF 50 and Personnelle Sport Sunscreen Lotion SPF 50 have been voluntarily recalled by Empack Spraytech Inc. because of bacterial contamination.

Health Canada

16-11-2018

Setting of an import tolerance for pyraclostrobin in rice

Setting of an import tolerance for pyraclostrobin in rice

Published on: Thu, 15 Nov 2018 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant BASF SE submitted a request to the competent national authority in Germany to set an import tolerance for the active substance pyraclostrobin in rice. The data submitted in support of the request were found to be sufficient to derive a maximum residue level (MRL) proposal for rice. Based on the risk assessment results, EFSA concluded that the short‐term intake of residues resulting from the use of p...

Europe - EFSA - European Food Safety Authority Publications

15-11-2018

Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for chickens for fattening and chickens reared for laying

Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for chickens for fattening and chickens reared for laying

Published on: Wed, 14 Nov 2018 The coccidiostat Monimax® (monensin sodium and nicarbazin) is considered safe for chickens for fattening and chickens reared for laying at the highest use level of 50 mg monensin and 50 mg nicarbazin/kg complete feed. This conclusion is extended to chickens reared for laying. For both active substances, the metabolic pathways in the chicken are similar to those in the turkey and rat. Nicarbazin, when ingested, is rapidly split in its two components dinitrocarbanilide (DNC)...

Europe - EFSA - European Food Safety Authority Publications

13-11-2018

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

On September 26, 2018 Oscor notified customers of a recall for certain lots (Recall No. 1035166- 09/07/2018-01-R) of TB Unshrouded Bipolar Pacing Leads. As part of the recall correction activities, Oscor is retrieving any remaining inventory out in the field. The recall scope is being expanded to include expired inventory for devices distributed between December 21, 2011 to May 17, 2018. The recall expansion is to ensure proper disposition of expired units. The FDA has been notified and is aware Oscor In...

FDA - U.S. Food and Drug Administration

10-11-2018

Pest categorisation of Popillia japonica

Pest categorisation of Popillia japonica

Published on: Thu, 08 Nov 2018 00:00:00 +0100 The Panel on Plant Health performed a pest categorisation of Popillia japonica(Coleoptera: Scarabaeidae) for the EU. P. japonica is a distinguishable species listed in Annex IAII of Council Directive 2000/29/EC. It is native to Japan but established in the USA in the early 20th century. It spreads from New Jersey to most US states east of the Mississippi, some to the west and north into Canada. P. japonica feeds on over 700 plant species. Adults attack folia...

Europe - EFSA - European Food Safety Authority Publications

9-11-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen and modernize agency’s oversight and reporting of inspections for sterile injectable drugs

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen and modernize agency’s oversight and reporting of inspections for sterile injectable drugs

FDA is taking steps to modernize the agency’s inspections program

FDA - U.S. Food and Drug Administration

9-11-2018

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Published on: Wed, 07 Nov 2018 00:00:00 +0100 The EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP Panel) assessed the safety of the additive Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials. It is a family of mixtures combining the four lanthanides lanthanum (La), europium (Eu), gadolinium (Gd) and/or terbium (Tb) in different proportions as their 1,4‐benzene dicarboxylate complexes, used as a taggant in plastics for authentication and ...

Europe - EFSA - European Food Safety Authority Publications

8-11-2018

Manage Your Asthma: Know Your Triggers and Treatment Options

Manage Your Asthma: Know Your Triggers and Treatment Options

You can manage your asthma by taking medications approved by the FDA. Before going to the pharmacy, get a proper diagnosis from a doctor and together develop an asthma action plan.

FDA - U.S. Food and Drug Administration

5-11-2018

November 5, 2018: Nurse Sentenced for Taking Fentanyl for Personal Use

November 5, 2018: Nurse Sentenced for Taking Fentanyl for Personal Use

November 5, 2018: Nurse Sentenced for Taking Fentanyl for Personal Use

FDA - U.S. Food and Drug Administration

5-11-2018

Products containing metam-sodium: ANSES announces the withdrawal of marketing authorisations

Products containing metam-sodium: ANSES announces the withdrawal of marketing authorisations

Plant protection products containing metam-sodium are used in market gardening and horticulture to disinfect the soil. Following the substance's approval at European level, ANSES reassessed the dossiers and notified the industrial companies concerned of its intention to withdraw all marketing authorisations for metam-sodium products. ANSES is also taking this opportunity to reiterate the importance of phytopharmacovigilance and the requirement for professionals to report any adverse effects on humans or ...

France - Agence Nationale du Médicament Vétérinaire

2-11-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s approval of Dsuvia and the FDA’s future consideration of new opioids

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s approval of Dsuvia and the FDA’s future consideration of new opioids

FDA announces approval of Dsuvia and new steps the agency may be taking to evaluate opioids.

FDA - U.S. Food and Drug Administration

31-10-2018

Chapter Plus+ By Backslim Capsules

Chapter Plus+ By Backslim Capsules

Chapter Plus+ By Backslim Capsules pose a serious risk to your health and should not be taken

Therapeutic Goods Administration - Australia

14-1-2019

Video: About the Therapeutic Goods Administration

Video: About the Therapeutic Goods Administration

A short video to take you through who we are and what we do

Therapeutic Goods Administration - Australia

20-12-2018

2018 survey results: TGA trusted but not yet a household name

2018 survey results: TGA trusted but not yet a household name

2018 TGA stakeholder survey reports available

Therapeutic Goods Administration - Australia

17-12-2018


Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Angioedemas, Hereditary, Date of authorisation: 22/11/2018, Status: Authorised

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Angioedemas, Hereditary, Date of authorisation: 22/11/2018, Status: Authorised

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Angioedemas, Hereditary, Date of authorisation: 22/11/2018, Status: Authorised

Europe - EMA - European Medicines Agency

4-12-2018


Review and update of EMA guidelines to implement best practice with regard to 3Rs (replacement, reduction and refinement) in regulatory testing of medicinal products – report on actions taken

Review and update of EMA guidelines to implement best practice with regard to 3Rs (replacement, reduction and refinement) in regulatory testing of medicinal products – report on actions taken

Review and update of EMA guidelines to implement best practice with regard to 3Rs (replacement, reduction and refinement) in regulatory testing of medicinal products – report on actions taken

Europe - EMA - European Medicines Agency

30-11-2018

#FDA In Brief: @US_FDA takes steps to advance the safety and accuracy of  blood glucose monitors to empower patients with diabetes with reliable  tools to manage their health. Read more:  https://go.usa.gov/xPMyA   #MedicalDevice

#FDA In Brief: @US_FDA takes steps to advance the safety and accuracy of blood glucose monitors to empower patients with diabetes with reliable tools to manage their health. Read more: https://go.usa.gov/xPMyA  #MedicalDevice

#FDA In Brief: @US_FDA takes steps to advance the safety and accuracy of blood glucose monitors to empower patients with diabetes with reliable tools to manage their health. Read more: https://go.usa.gov/xPMyA  #MedicalDevice

FDA - U.S. Food and Drug Administration

26-11-2018

Today, #FDA’s device center also posted performance report highlighting measures taken to increase predictability, transparency of 510(k) review process, incl. 50 final guidance documents on important medical device policy issues issued since 2009.  https

Today, #FDA’s device center also posted performance report highlighting measures taken to increase predictability, transparency of 510(k) review process, incl. 50 final guidance documents on important medical device policy issues issued since 2009. https

Today, #FDA’s device center also posted performance report highlighting measures taken to increase predictability, transparency of 510(k) review process, incl. 50 final guidance documents on important medical device policy issues issued since 2009. https://go.usa.gov/xPHdn 

FDA - U.S. Food and Drug Administration

26-11-2018

TAKHZYRO (Shire Pharmaceuticals Ireland Limited)

TAKHZYRO (Shire Pharmaceuticals Ireland Limited)

TAKHZYRO (Active substance: lanadelumab) - Centralised - Authorisation - Commission Decision (2018)7971 of Mon, 26 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/004806/0000

Europe -DG Health and Food Safety

26-11-2018

Alunbrig (Takeda Pharma A/S)

Alunbrig (Takeda Pharma A/S)

Alunbrig (Active substance: brigatinib) - Centralised - Authorisation - Commission Decision (2018)7976 of Mon, 26 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4248/

Europe -DG Health and Food Safety

23-11-2018

Management and communication of medicine shortages and discontinuations in Australia

Management and communication of medicine shortages and discontinuations in Australia

Guidance for sponsors and other stakeholder bodies

Therapeutic Goods Administration - Australia

21-11-2018

EU/3/18/2082 (Takeda Pharma A/S)

EU/3/18/2082 (Takeda Pharma A/S)

EU/3/18/2082 (Active substance: 5-{(1R,2R)-2-[(cyclopropylmethyl)amino]cyclopropyl}-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide monohydrochloride) - Orphan designation - Commission Decision (2018)7791 of Wed, 21 Nov 2018 European Medicines Agency (EMA) procedure number: EMA/OD/040/18

Europe -DG Health and Food Safety

20-11-2018

Are you traveling with some yummy food for #Thanksgiving this year? Take a few minutes to learn some #foodsafety tips to make sure you & your family don’t get sick.  http://go.usa.gov/xPXzH pic.twitter.com/tTpNUmwzcm

Are you traveling with some yummy food for #Thanksgiving this year? Take a few minutes to learn some #foodsafety tips to make sure you & your family don’t get sick. http://go.usa.gov/xPXzH pic.twitter.com/tTpNUmwzcm

Are you traveling with some yummy food for #Thanksgiving this year? Take a few minutes to learn some #foodsafety tips to make sure you & your family don’t get sick. http://go.usa.gov/xPXzH  pic.twitter.com/tTpNUmwzcm

FDA - U.S. Food and Drug Administration

6-11-2018

Communication to stakeholders: Autologous human cells and tissues (HCT) products

Communication to stakeholders: Autologous human cells and tissues (HCT) products

Important information about potential impact of regulation changes that came in force on 1 July 2018

Therapeutic Goods Administration - Australia

31-10-2018

Therapeutic goods advertising: Update 31 October 2018

Therapeutic goods advertising: Update 31 October 2018

The 2018 Code No.2 made today replaces the code that was made on 29 June 2018, and will take effect on 1 January 2019

Therapeutic Goods Administration - Australia